PriceTargets.com logo

Canopy Growth - CGC Stock Price Target and Predictions

  • Consensus Rating: Reduce
  • Consensus Price Target: $3.50
  • Forecasted Upside: -6.91%
  • Number of Analysts: 3
  • Breakdown:
  • 1 Sell Ratings
  • 2 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$3.76 As of 11/20/2024 01:00 AM ET
▼ -0.07 (-1.83%)

This chart shows the closing price for CGC by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Canopy Growth Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CGC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CGC

Analyst Price Target is $3.50
▼ -6.91% Downside Potential
This price target is based on 3 analysts offering 12 month price targets for Canopy Growth in the last 3 months. The average price target is $3.50, with a high forecast of $5.00 and a low forecast of $2.00. The average price target represents a -6.91% upside from the last price of $3.76.

This chart shows the closing price for CGC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Reduce

The current consensus among 3 investment analysts is to reduce stock in Canopy Growth. This rating has held steady since May 2024, when it changed from a Sell consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 3 buy ratings
  • 5 hold ratings
  • 3 sell ratings
Ratings as of
5/30/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 1 sell ratings
Ratings as of
8/28/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 1 sell ratings
Ratings as of
11/26/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 2 sell ratings
Ratings as of
2/24/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 2 sell ratings
Ratings as of
5/24/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 2 sell ratings
Ratings as of
8/22/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 1 sell ratings
Ratings as of
10/21/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 1 sell ratings
Ratings as of
11/20/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
7/9/2024Piper SandlerLower TargetUnderweight ➝ Underweight$3.00 ➝ $2.00
6/17/2024Atb Cap MarketsUpgradeHold
2/12/2024Piper SandlerLower TargetUnderperform$5.00 ➝ $3.00
1/31/2024Sanford C. BernsteinBoost TargetMarket Perform$5.00
9/15/2023Bank of AmericaBoost TargetUnderperform ➝ Underperform$5.60 ➝ $6.60
5/2/2023Piper SandlerLower Target$20.00 ➝ $10.00
5/1/2023BMO Capital MarketsUpgradeUnderperform ➝ Market Perform
4/4/2023Sanford C. BernsteinUpgradeUnderperform ➝ Market Perform
2/17/2023Cantor FitzgeraldLower TargetNeutral$33.00 ➝ $32.00
2/13/2023Roth CapitalReiterated RatingBuy
2/10/2023CIBCLower TargetC$25.00 ➝ C$17.50
2/9/2023Alliance Global PartnersLower TargetC$45.00 ➝ C$35.00
2/1/2023CIBCLower TargetC$30.00 ➝ C$25.00
11/7/2022Canaccord Genuity GroupBoost TargetHold ➝ HoldC$42.50 ➝ C$50.00
11/1/2022Sanford C. BernsteinInitiated CoverageUnderperform$15.00
10/26/2022Canaccord Genuity GroupUpgradeSell ➝ HoldC$27.50 ➝ C$42.50
10/26/2022Cantor FitzgeraldBoost TargetNeutral$29.00 ➝ $30.50
10/25/2022Alliance Global PartnersBoost TargetC$35.00 ➝ C$40.00
9/30/2022BarclaysLower TargetUnderweight$35.00 ➝ $20.00
8/8/2022Piper SandlerLower TargetUnderweight$30.00 ➝ $25.00
7/5/2022Bank of AmericaLower TargetUnderperform ➝ Underperform$30.00 ➝ $23.30
7/1/2022Canaccord Genuity GroupLower TargetSell ➝ SellC$45.00 ➝ C$35.00
6/30/2022Piper SandlerLower TargetUnderweight$40.00 ➝ $30.00
6/29/2022MKM PartnersLower TargetBuy ➝ BuyC$170.00 ➝ C$130.00
6/8/2022BMO Capital MarketsDowngradeMarket Perform ➝ Underperform
6/8/2022BarclaysLower TargetUnderweight$60.00 ➝ $35.00
6/1/2022OppenheimerReiterated RatingMarket Perform
5/31/2022Canaccord Genuity GroupLower TargetC$60.00 ➝ C$45.00
5/31/2022CIBCLower TargetC$65.00 ➝ C$50.00
5/31/2022Piper SandlerLower TargetUnderweight$60.00 ➝ $40.00
5/30/2022CowenLower TargetBuy$50.00
5/27/2022CfraReiterated RatingHold$100.00
5/27/2022Alliance Global PartnersLower TargetC$80.00 ➝ C$70.00
5/27/2022BenchmarkDowngradeHold ➝ Sell
5/20/2022Alliance Global PartnersLower TargetC$110.00 ➝ C$80.00
3/22/2022BarclaysDowngradeEqual Weight ➝ Underweight
3/1/2022BarclaysLower TargetEqual Weight$140.00 ➝ $90.00
2/18/2022Cantor FitzgeraldBoost TargetNeutralC$96.00 ➝ C$110.00
2/10/2022Canaccord Genuity GroupLower TargetC$120.00 ➝ C$100.00
2/3/2022CIBCLower TargetC$120.00 ➝ C$90.00
1/28/2022Cantor FitzgeraldLower TargetC$163.00 ➝ C$96.00
1/7/2022Alliance Global PartnersLower TargetNeutral ➝ NeutralC$180.00 ➝ C$110.00
12/22/2021Bank of AmericaDowngradeNeutral ➝ Underperform$190.00 ➝ $100.00
12/20/2021Piper SandlerDowngradeNeutral ➝ Underweight$110.00 ➝ $70.00
12/6/2021Wells Fargo & CompanyInitiated CoverageUnderweight$80.00
11/30/2021Eight CapitalDowngradeNeutral ➝ Sell
11/23/2021Jefferies Financial GroupLower TargetPositive ➝ HoldC$252.80 ➝ C$167.00
11/18/2021Bank of AmericaLower TargetNeutralC$220.00 ➝ C$190.00
11/18/2021BarclaysInitiated CoverageEqual Weight$140.00
11/8/2021CowenDowngradeOutperform ➝ Market Perform$266.90 ➝ $216.00
11/8/2021CIBCDowngradeNeutral ➝ Underperform
11/5/2021Alliance Global PartnersLower TargetNeutralC$200.00 ➝ C$180.00
10/14/2021Alliance Global PartnersLower TargetNeutralC$250.00 ➝ C$200.00
10/1/2021Bank of AmericaDowngradeBuy ➝ Neutral
9/23/2021CIBCLower TargetNeutralC$270.00 ➝ C$220.00
9/20/2021Cantor FitzgeraldLower TargetPositive ➝ NeutralC$305.00 ➝ C$210.00
9/20/2021Piper SandlerLower TargetPositive ➝ Neutral$190.00 ➝ $150.00
8/11/2021Jefferies Financial GroupUpgradeUnderperform ➝ Hold
8/9/2021CIBCLower TargetNeutralC$300.00 ➝ C$270.00
7/8/2021Piper SandlerLower TargetNeutral$270.00 ➝ $240.00
6/3/2021DesjardinsLower TargetHoldC$550.00 ➝ C$350.00
6/2/2021CIBCLower TargetNeutralC$380.00 ➝ C$360.00
6/2/2021Eight CapitalUpgradeSell ➝ Neutral
6/1/2021Alliance Global PartnersReiterated RatingNeutral$400.00 ➝ $320.00
5/25/2021MKM PartnersUpgradeNeutral ➝ Buy$550.00
5/11/2021CIBCLower TargetNeutral$550.00 ➝ $380.00
4/28/2021Bank of AmericaInitiated CoverageBuy
4/9/2021Cantor FitzgeraldLower TargetNeutral$620.00 ➝ $350.00
4/8/2021Alliance Global PartnersLower TargetUnderperform ➝ Neutral$600.00 ➝ $400.00
4/5/2021CIBCLower TargetNeutral$640.00 ➝ $550.00
2/24/2021Jefferies Financial GroupDowngradeHold ➝ Underperform
2/11/2021DesjardinsBoost TargetHold$220.00 ➝ $550.00
2/10/2021CIBCBoost TargetNeutral$320.00 ➝ $640.00
2/10/2021CormarkDowngradeMarket Perform ➝ Reduce
2/10/2021BMO Capital MarketsReiterated RatingMarket Perform
2/10/2021Cantor FitzgeraldBoost TargetNeutral$500.00 ➝ $620.00
2/10/2021BenchmarkDowngradeBuy ➝ Hold
2/5/2021Piper SandlerDowngradeOverweight ➝ Neutral$270.00
2/4/2021Stifel NicolausReiterated RatingBuy$230.00
1/5/2021Cantor FitzgeraldBoost TargetNeutral$290.00 ➝ $330.00
11/16/2020Jefferies Financial GroupBoost TargetHold$160.00 ➝ $211.00
11/11/2020CIBCBoost TargetNeutral$250.00 ➝ $320.00
9/4/2020CfraUpgradeBuy ➝ Strong-Buy
8/21/2020OppenheimerReiterated RatingHold
6/22/2020OppenheimerInitiated CoverageHold
6/1/2020ScotiabankBoost TargetSector Perform$280.00 ➝ $330.00
6/1/2020LADENBURG THALM/SH SHDowngradeBuy ➝ Neutral
6/1/2020Alliance Global PartnersBoost TargetNeutral$240.00 ➝ $300.00
6/1/2020Pi FinancialDowngradeNeutral ➝ Sell
6/1/2020BMO Capital MarketsDowngradeOutperform ➝ Market Perform
6/1/2020Bryan, Garnier & CoDowngradeNeutral ➝ Sell
6/1/2020Stifel NicolausDowngradeBuy ➝ Sell
6/1/2020CIBCDowngradeOutperform ➝ Neutral
5/26/2020Pi FinancialReiterated RatingNeutral ➝ Neutral
5/22/2020Bank of AmericaInitiated CoverageBuy
5/14/2020Cantor FitzgeraldLower TargetNeutral$270.00 ➝ $250.00
4/16/2020Jefferies Financial GroupUpgradeUnderperform ➝ Hold$173.00 ➝ $156.00
3/5/2020Laurentian Bank of CanadaUpgradeBuy
3/5/2020LaurentianUpgradeBuy
2/18/2020CIBCReiterated RatingBuy$350.00
2/18/2020Stifel NicolausBoost TargetBuy$300.00 ➝ $350.00
2/14/2020Pi FinancialDowngradeHold$300.00
2/5/2020OppenheimerReiterated RatingHold
1/28/2020Bank of AmericaReiterated RatingBuy$360.00
1/28/2020BMO Capital MarketsUpgradeMarket Perform ➝ Outperform$400.00
12/12/2019Cantor FitzgeraldBoost TargetNeutral$189.00 ➝ $270.00
12/9/2019Cantor FitzgeraldReiterated RatingHold$142.70
12/5/2019MKM PartnersReiterated RatingHold$230.00
11/29/2019Eight CapitalDowngradeHold$250.00
11/27/2019Bank of AmericaUpgradeNeutral ➝ Buy
(Data available from 11/21/2019 forward)

News Sentiment Rating

0.73 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 43 very positive mentions
  • 15 positive mentions
  • 10 negative mentions
  • 0 very negative mentions
Mentions as of
4/24/2024
  • 27 very positive mentions
  • 17 positive mentions
  • 6 negative mentions
  • 0 very negative mentions
Mentions as of
5/24/2024
  • 22 very positive mentions
  • 8 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
6/23/2024
  • 11 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/23/2024
  • 21 very positive mentions
  • 20 positive mentions
  • 4 negative mentions
  • 0 very negative mentions
Mentions as of
8/22/2024
  • 4 very positive mentions
  • 5 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
9/21/2024
  • 2 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
10/21/2024
  • 7 very positive mentions
  • 9 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
11/20/2024

Current Sentiment

  • 7 very positive mentions
  • 9 positive mentions
  • 2 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Canopy Growth logo
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments. The company offers dried flower, pre-rolled joints, oils, softgel capsules, infused beverages, edibles comprising gummies, and topical formats, as well as vaporizer devices. It sells its products under the Tweed, 7ACRES, DOJA, Deep Space, HiWay, Maitri, Twd., Vert, Spectrum Therapeutics, Canopy Medical, Storz & Bickel, Martha Stewart, and Wana brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.
Read More

Today's Range

Now: $3.76
Low: $3.75
High: $3.85

50 Day Range

MA: $4.50
Low: $3.73
High: $5.59

52 Week Range

Now: $3.76
Low: $2.76
High: $14.92

Volume

2,921,478 shs

Average Volume

7,967,667 shs

Market Capitalization

$396.15 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.87

Frequently Asked Questions

What sell-side analysts currently cover shares of Canopy Growth?

The following Wall Street sell-side analysts have issued reports on Canopy Growth in the last year: Atb Cap Markets, Piper Sandler, and Sanford C. Bernstein.
View the latest analyst ratings for CGC.

What is the current price target for Canopy Growth?

0 Wall Street analysts have set twelve-month price targets for Canopy Growth in the last year. Their average twelve-month price target is $3.50, suggesting a possible downside of 6.9%. Sanford C. Bernstein has the highest price target set, predicting CGC will reach $5.00 in the next twelve months. Piper Sandler has the lowest price target set, forecasting a price of $2.00 for Canopy Growth in the next year.
View the latest price targets for CGC.

What is the current consensus analyst rating for Canopy Growth?

Canopy Growth currently has 1 sell rating and 2 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Reduce."
View the latest ratings for CGC.

What other companies compete with Canopy Growth?

Other companies that are similar to Canopy Growth include Arvinas, Kiniksa Pharmaceuticals, Spyre Therapeutics, Travere Therapeutics and Ocular Therapeutix. Learn More about companies similar to Canopy Growth.

How do I contact Canopy Growth's investor relations team?

Canopy Growth's physical mailing address is 1 HERSHEY DRIVE, SMITH FALLS A6, K7A0A8. The company's listed phone number is (855) 558-9333 and its investor relations email address is [email protected]. The official website for Canopy Growth is www.canopygrowth.com. Learn More about contacing Canopy Growth investor relations.